All our products are now available.

A-SKIN has received permission from the Dutch Health Inspectorate (Inspectie voor de Gezondheidszorg IGZ) to provide Tiscover, KC-Matrix and AS210 to individual patients from any Hospital in the Netherlands. The permission was granted on the basis of the favorable preliminary safety and efficacy data and, regarding Tiscover and KC-Matrix, also the National and EU Hospital Exemption regulation. Both latter products, therefore, can be administered only to limited numbers of patients. This holds for any patient who cannot be included in ongoing studies, at the judgement of the specialist(s) involved. Reimbursement of the costs is still negotiated, but costs will not exceed production costs. For Tiscover, patients with difficult to treat leg ulcers are first considered for inclusion in the ongoing trial  More  information

Back to top